NFKB1 and lung carcinoma: In conclusion, it is the first time that fucoidan is revealed to inhibit MMP-2 activity via the suppression of PI3K-Akt-mTOR and NF-kB signaling pathway in A549 lung cancer cells, resulting in the down regulation of cancer cell migration and invasion.